Glenmark Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a wide range of branded and generic drugs across various therapeutic areas. Founded in 1977 and headquartered in Mumbai, India, Glenmark operates in more than 80 countries worldwide, with a strong presence in emerging markets. The company's product portfolio includes medicines for dermatology, respiratory, oncology, and cardiovascular conditions, among others. Glenmark is known for its commitment to innovation, with significant investments in research and development, particularly in biologics and complex generics. The company focuses on improving healthcare through affordable and effective treatments, as well as collaborating with global partners to address unmet medical needs.